3320 — China Resources Pharmaceutical Share News
0.000.00%
- HK$28.93bn
- HK$167.93bn
- CNY269.57bn
Brief: China Resources Pharmaceutical Reports 9M Revenue For Jiangzhong Pharmaceutical RMB 2.93 Billion
Brief: China Resources Pharmaceutical Group Posts H1 Net Income RMB 5,053.6 Million
Brief: China Resources Pharmaceutical Posts HY Revenue RMB1.01 Bln For CR Boya Bio-Pharmaceutical
Brief: China Resources Pharmaceutical Reports HY Net Profit Attributable For CR Double-Crane RMB975.5 Million
Brief: China Resources Pharmaceutical Posts HY Results For KPC Pharmaceuticals
Brief: China Resources Pharmaceutical's Units Discus Formation Of RMB500 Million Fund
Brief: China Resources Pharmaceutical Announces Formation Of Fund
Brief: China Resources Pharmaceutical Posts Qtrly Net Profit Of Jiangzhong Pharmaceutical RMB306.7 Million
Brief: China Resources Pharmaceutical Says QTRLY Net Profit Rmb425.0 Million For Dong-E-E-Jiao
Brief: China Resources Pharmaceutical Posts Qtrly Results For China Resources Boya Bio-Pharmaceutical
Brief: China Resources Pharmaceutical Says FY Net Income RMB 8,403.2 Million
Brief: China Resources Pharmaceutical Says FY Net Profit Attributable For Jiangzhong Pharmaceutical Was RMB788.2 Million
Brief: China Resources Pharmaceutical Posts FY Results For CR Double-Crane Pharmaceutical
Brief: China Resources Pharmaceutical Posts FY Net Profit Attributable Of CR Boya Bio-Pharmaceutical Of RMB397 Million
Brief: China Resources Pharmaceutical Posts FY Revenue RMB5.92 Bln For Dong-E-E-Jiao
Brief: China Resources Pharmaceutical Announces KPC Pharmaceuticals FY Results
Brief: China Resources Pharmaceutical Sees Net Profit Attributable RMB784.9 Mln For Jiangzhong Pharmaceutical
Brief: China Resources Pharmaceutical Sees FY Net Profit Attributable Of Dong-E-E-Jiao RMB1,500 Million To RMB1,600 Million
Brief: China Resources Pharmaceutical Says Unit Issued Perpetual Bonds In PRC